Clovis Oncology Inc (NASDAQ:CLVS)

3.66
Delayed Data
As of 4:00pm ET
 +0.46 / +14.38%
Today’s Change
3.01
Today|||52-Week Range
32.05
-79.62%
Year-to-Date
3 Beaten-Up Biotechs -- Are They Buys?
Oct 13 / MotleyFool.com - Paid Partner Content
3 Cancer Treatment Stocks to Buy Right Now
Oct 10 / MotleyFool.com - Paid Partner Content
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Oct 11 / MotleyFool.com - Paid Partner Content
Clovis Gains Rights to Pre-Clinical Cancer Program for $12M
Sep 24 / Zacks.com - Paid Partner Content